In line with what has been found in adult DCM patients (van Dijk et al., 2009; Bollen et al., 2017b), we observed decreased cTnI phosphorylation which caused an increase in Ca2+-sensitivity in end-stage pediatric CM patients compared to controls. This evidence concerns the gene TNNI3 and cutaneous mastocytosis.